No significant enhancement of protection by Tat-expressing Sendai viral vector-booster in a macaque AIDS model
- 1 June 2003
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (9) , 1392-1394
- https://doi.org/10.1097/00002030-200306130-00015
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Comparison of the efficacy of early versus late viral proteins in vaccination against SIVVaccine, 2002
- Primary replication of a recombinant Sendai virus vector in macaquesJournal of General Virology, 2002
- Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 ReplicationJournal of Virology, 2002
- The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?Nature Reviews Immunology, 2002
- Rapid Appearance of Secondary Immune Responses and Protection from Acute CD4 Depletion after a Highly Pathogenic Immunodeficiency Virus Challenge in Macaques Vaccinated with a DNA Prime/Sendai Virus Vector Boost RegimenJournal of Virology, 2001
- Quantifying the uncertainty in forecasts of anthropogenic climate changeNature, 2000
- Induction of protective immunity against pathogenic simian immunodeficiency virus by a foreign receptor-dependent replication of an engineered avirulent virusVaccine, 2000
- Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaquesProceedings of the National Academy of Sciences, 2000
- Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineNature Medicine, 1999
- The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesisThe EMBO Journal, 1997